| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |